Legal Representation
Attorney
Susan Weller
USPTO Deadlines
Next Deadline
241 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
March 12, 2026
Extension Available
Until September 12, 2024
Application History
33 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 25, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Mar 25, 2025 | EXT4 | S | SOU EXTENSION 4 FILED |
| Mar 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 16, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Dec 16, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Dec 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 19, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 19, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Aug 19, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 2, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 31, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 31, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 31, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Sep 12, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 18, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 18, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 28, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 9, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 7, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 7, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 7, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jan 31, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jan 31, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Dec 9, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Dec 9, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Dec 9, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 6, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 27, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Apr 26, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 22, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases
Class 042
research and development in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases; scientific research in the nature of conducting medical and scientific research, namely, conducting clinical trials for others in the field of small molecule medicines for the treatment of conditions and diseases in the fields of cancer, neurology, immunology, cardiovascular disease, monogenic diseases, and metabolic diseases
Additional Information
Design Mark
The mark consists of three shaded circles connected by three sperate sets of curved lines to form a triangle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
USPTO Documents
Loading USPTO documents...